Tuesday, September 26, 2017

Substance Abuse/Addiction

The Most Promoted Drugs are Those with Little Therapeutic Value, Study Finds

Majority of top-selling and most promoted drugs in Canada are rated as having very limited safety and efficacy.

Reflections on the Cruel and Subtle Costs of Racism and Bigotry

In this essay for the Psychiatric Times, Dr. Edward Khantzian reflects on the pain and grief caused by all forms of racism and bigotry, from...

Trauma-Ignored Care? Going to the MAT on Opioids

Our current, reductionistic approach to mental health issues doesn’t offer any insights or explanations on the etiology of most mental disturbances. Similarly, medication assisted treatment (MAT) focuses on the surface symptoms of opiate abuse without addressing the underlying causes of overwhelming distress and pain.

Proove Biosciences Sells Off Assets as CEO Departs

From STAT: Proove Biosciences, which sold dubious DNA tests to predict opioid addiction risk, has been placed into court-ordered receivership for restructuring and asset sale. Experts...

Why Addiction Language is Harmful

In this video for Benzo Brains, Jocelyn Pedersen explains why addiction is harmful to benzodiazepine survivors and differentiates benzodiazepine associated disability (BAD) from benzodiazepine addiction.

The Real Opioid Emergency

From The New York Times: In recent years, politicians have shown increased awareness of the opioid epidemic and have made statements about the need for treatment,...

Abilify: The Drug That Could Gamble Your Life Away

On this episode of America's Lawyer, Mike Papantonio discusses the numerous lawsuits pending involving the anti-psychotic drug Abilify, which has caused plaintiffs to develop serious...

Time on a Therapist’s Couch Yields Personality Changes

From Ars Technica: A recent meta-analysis found that a variety of different therapeutic techniques result in positive personality changes. The two personality traits most impacted...

Researchers Question the “Adequacy and Legitimacy” of ADHD Diagnosis

A new article, just published online in the journal Emotional and Behavioural Difficulties, presents research suggesting that the diagnosis of ADHD is philosophically inadequate.

My Grandmother is a Drug Addict—and I Blame Big Pharma

In this piece for Alternet, Joshua Wilkey discusses his grandmother's addiction to opioid painkillers and details the role that pharmaceutical companies have played in Appalachia's opioid...

We Need to Change the way we Think About Alcoholism

From Massive: The public generally conceptualizes alcoholism as a biological brain disease and rejects the notion that social and cultural factors may contribute to addiction....

There’s Little Evidence Abuse-Deterrent Opioids Work

From STAT: In recent years, the pharmaceutical industry has proposed using abuse-deterrent opioids - those that make it more difficult to crush, snort, or inject...

‘Ego-Dissolving’ Psychedelic Drugs Could Improve Mental Health

From Medical Xpress: Researchers have proposed that psychedelic drugs such as LSD and magic mushrooms may help some people with anxiety, depression, and addiction by dissolving...

Creative Approach to Mental Health Underfunded

From Stuff: Ōtautahi Creative Spaces, a center that offers art therapy workshops, was recently set up in response to the earthquakes in Christchurch, New Zealand, where...

What if we are all Wrong About Mental Illness?

From Thoughtful Living: The biomedical model of psychiatry, along with the DSM, is deeply flawed and can often be misleading. To improve, mental health services...

Marshmallows Aren’t Likely to Fix Low-Income Kids’ Problems

From BOLD Blog: Starting in the late 1960s, researchers conducted an experiment offering young children a choice between one marshmallow at the present or two...

How Complex Trauma Changes a Person

From GoodTherapy.org: Although not currently listed in the DSM, the diagnosis of complex post-traumatic stress (C-PTSD) has gained widespread acceptance in the mental health community. The...

New Study Asks Doctors About Barriers to Deprescribing

Researchers interviewed doctors about the barriers that prevent them from being able to decrease excess medications.

The Promise of LSD Microdoses and Other Psychedelics

In this interview for Scientific American, psychiatrist John Halpern discusses some of the potentially therapeutic effects of peyote, ayahuasca, psilocybin, MDMA and other psychedelics. "Once when...

New Study Examines User Experience of Discontinuing Psychiatric Medications

Researchers find that support and self-care were helpful for users during discontinuation, but that mental health professionals were not very helpful.

In Texas, People With Mental Illness Find Work Helping Peers

From Kaiser Health News: Peer support for people diagnosed with serious mental illness is becoming increasingly common. In places like Texas, where there is a...

Why Are So Many People Dying From Opioid Overdoses?

From The Guardian: In a society where unemployment is prevalent and people feel isolated from friends, family, and community, opioid use has become a coping...

Gabapentin: A New Target for Abuse

From STAT: Gabapentin, a drug that acts as a sedative and is also used to treat conditions including nerve pain, epilepsy, restless leg syndrome, and...

Jerome Adams Nominated as New U.S. Surgeon General

From STAT: President Trump has nominated Indiana's health commissioner, Dr. Jerome Adams, to be the next surgeon general. Adams has played a critical role in...

When Anxiety or Depression Masks a Medical Problem

From The New York Times: The mind and body are more connected than we often think — symptoms of anxiety and depression may result from...

Follow Us

19,394FansLike
10,244FollowersFollow
1,376SubscribersSubscribe